Hyperglycemic myocardial damage is mediated by proinflammatory cytokine: macrophage migration inhibitory factor - Test2 - elhamkhani - TriplyDB

Hyperglycemic myocardial damage is mediated by proinflammatory cytokine: macrophage migration inhibitory factor

Hyperglycemic myocardial damage is mediated by proinflammatory cytokine: macrophage migration inhibitory factor

http://www.wikidata.org/entity/Q33808721

about

Cytokinome profile of patients with type 2 diabetes and/or chronic hepatitis C infection Heme oxygenase-1 prevents cardiac dysfunction in streptozotocin-diabetic mice by reducing inflammation, oxidative stress, apoptosis and enhancing autophagy Elevated serum levels of macrophage migration inhibitory factor are associated with progressive chronic cardiomyopathy in patients with Chagas disease.Macrophage migration inhibitory factor inhibition is deleterious for high-fat diet-induced cardiac dysfunction.Association of plasma angiotensin-(1-7) level and left ventricular function in patients with type 2 diabetes mellitus Role of Macrophage Migration Inhibitory Factor in Obesity, Insulin Resistance, Type 2 Diabetes, and Associated Hepatic Co-Morbidities: A Comprehensive Review of Human and Rodent Studies Mannose binding lectin and macrophage migration inhibitory factor gene polymorphisms in Turkish children with cardiomyopathy: no association with MBL2 codon 54 A/B genotype, but an association between MIF -173 CC genotype.Early cardiac changes in a rat model of prediabetes: brain natriuretic peptide overexpression seems to be the best marker.Macrophage Migration Inhibitory Factor and Malondialdehyde as Potential Predictors of Vascular Risk Complications in Type 2 Diabetes Mellitus: Cross-Sectional Case Control Study in Saudi Arabia The role of MIF in type 1 and type 2 diabetes mellitus.Activation of toll-like receptors and inflammasome complexes in the diabetic cardiomyopathy-associated inflammation.Abnormalities of the cardiac stem and progenitor cell compartment in experimental and human diabetes.Differentiation-dependent doxorubicin toxicity on H9c2 cardiomyoblasts.Ulinastatin attenuates diabetes-induced cardiac dysfunction by the inhibition of inflammation and apoptosis.Rational Study Design is Important for Assessing Myocardial Protection of Anesthetics.Inflammatory factors contribute to depression and its comorbid conditions.Recent novel approaches to limit oxidative stress and inflammation in diabetic complications.The Role of Leukocytes in Diabetic Cardiomyopathy

P2860

Q28480545-8036612D-F7E0-4D5D-8940-5C966C2A5C2C Q28533775-CFC55BE3-0971-4CA6-86C5-E0F0681F1BFD Q34603215-2A3C86A5-42F4-41A2-B035-65211B15AE9B Q34639351-01F916DE-FE74-4889-9837-8604A1090CE1 Q34729883-FC615695-7A5A-4867-A489-8AB24A744F5E Q35741973-98F1FC2F-F17F-4539-BDC2-1FC2C5ACE45A Q36190213-2211EABF-C654-401B-BF3B-867919BF775C Q36690425-204999FC-EF67-4A5A-9C50-38C5F6F70300 Q36958777-FAF62011-F6C6-46D9-953E-7CB12BCA199A Q37542812-4207B89F-2B0F-4983-BAD7-7B28C5266E85 Q37679639-841E5D97-579E-4D29-99FD-DF7F2921A637 Q38114923-C47C3352-BB62-4C2F-839A-6C15AF1D5E59 Q39323215-2BBE805B-2B53-4142-A00C-B0B832077777 Q41672032-B4790A79-580C-44F8-938C-FFF3CA342544 Q42949865-CEC6AD0F-3434-420B-81DD-E19C7F99C774 Q48351417-0C9FCA4C-D563-41AF-B83A-1B147399CBEB Q54956778-1BB485E4-BB1C-416F-BDF8-0106D076E168 Q59132980-0D95577F-7849-4D6F-9FC3-82ED844A160D

P2860

Hyperglycemic myocardial damage is mediated by proinflammatory cytokine: macrophage migration inhibitory factor

http://www.wikidata.org/entity/Q33808721

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Hyperglycemic myocardial damag ...... ge migration inhibitory factor

@ast

Hyperglycemic myocardial damag ...... ge migration inhibitory factor

@en

type

label

Hyperglycemic myocardial damag ...... ge migration inhibitory factor

@ast

Hyperglycemic myocardial damag ...... ge migration inhibitory factor

@en

prefLabel

Hyperglycemic myocardial damag ...... ge migration inhibitory factor

@ast

Hyperglycemic myocardial damag ...... ge migration inhibitory factor

@en

P1433

Q33808721-AD3EC590-2F73-4BFC-ADCF-90DAEC818912

P1476

Q33808721-9C06C0C0-7D4B-4F6E-BE48-C0D13BF67757

P2093

Q33808721-21D2F384-8294-4B3E-BD79-009BE88527FE

Q33808721-4F06EDE6-E6C5-47F2-BF84-4717BD270391

Q33808721-546B0DB9-52C8-4068-910A-C5DB7E67EE19

Q33808721-77B48AAB-4BD6-4C25-83F7-406AF45B7CD7

Q33808721-79CE165B-8591-46A6-8C33-7DF072F21544

Q33808721-82FE7B45-549E-4035-89F3-7781BCF0E3E8

Q33808721-90397C5E-4D6B-4554-AEA5-B0AF182CBC2C

Q33808721-98F80AD3-EDB5-48CC-ADE8-CDF4C3897D5E

Q33808721-9FD3B587-7988-41CC-9DE2-87E194B4CABF

Q33808721-AFA3782F-DD8D-4FEA-8509-9A1DE7B080D8

P2860

Q33808721-0318E7FD-6F43-4439-AE08-9151B1897A36

Q33808721-07271976-708E-49BF-9EAA-CC7622366041

Q33808721-0CCAEFF7-3EB6-4867-A4E8-217CD2D31795

Q33808721-227C8FE0-C081-4239-92E1-95488AB0B42A

Q33808721-36C1D4A2-C8B6-4A11-B91B-E32427D7BA05

Q33808721-3BCFD3CC-9AD6-40FC-AF52-24CA4A264208

Q33808721-478C40F3-524A-4E20-A79F-37E327A89DF4

Q33808721-55D9FB10-2AA7-437E-A9BC-05B9BC65EB98

Q33808721-5E044BBB-1832-4B6A-80C2-5530E372E3E3

Q33808721-6B374CB7-23C8-4091-B726-78E2B7D21AA2

P304

Q33808721-4946B492-EC03-430D-8670-7A69B84E760B

P31

Q33808721-B4984043-236C-493D-AF3C-264EB872F6D9

P356

Q33808721-E8E7A5BE-90C7-4847-A8B2-ADCD5675980F

P407

Q33808721-7A74A955-FCA1-493A-90E5-41B9CA26E2DA

P433

Q33808721-6C16404C-9E39-4112-9941-5AC25CDC0A05

P478

Q33808721-56F0D91C-5C72-4C89-8F71-7B042480C4D1

P577

Q33808721-BCE247AC-6D4B-4909-901D-B1CD85536F25

P5875

Q33808721-B3A45785-C96A-43C4-A807-E50D860CD072

P698

Q33808721-7E31EFC7-9751-4BFC-8704-35CEDA421C6C

P921

Q33808721-B2DB4C86-B99E-43C2-B56E-D40858184A2A

Q33808721-DBD9E45B-4728-4FFB-A161-83CA072BC84D

P932

Q33808721-47778219-BEB4-4CEC-9F44-01C8FD25F5A9

P356

JOURNAL.PONE.0016239

P1433

P1476

Hyperglycemic myocardial damag ...... ge migration inhibitory factor

@en

P2093

Hong-Hong Tan

http://www.w3.org/2001/XMLSchema#string

Hong-Mei Chen

http://www.w3.org/2001/XMLSchema#string

Hua-Zhang Yang

http://www.w3.org/2001/XMLSchema#string

Jia-Liang Liang

http://www.w3.org/2001/XMLSchema#string

Min Yang

http://www.w3.org/2001/XMLSchema#string

Qiu-Xiong Lin

http://www.w3.org/2001/XMLSchema#string

Shu-Guang Lin

http://www.w3.org/2001/XMLSchema#string

Xi-Yong Yu

http://www.w3.org/2001/XMLSchema#string

Xiao-Hong Li

http://www.w3.org/2001/XMLSchema#string

Xiao-Ying Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Glucose induces apoptosis of cardiomyocytes via microRNA-1 and IGF-1

MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment

Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy.

Early atherosclerosis and vascular inflammation in mice with diet-induced type 2 diabetes.

Mechanisms of regulation of the expression and function of G protein-coupled receptor kinases.

MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis.

Macrophage migration inhibitory factor induces cardiomyocyte apoptosis.

Apoptotic signal transduction pathways in diabetes.

Molecular restoration of beta-adrenergic receptor signaling improves contractile function of failing hearts.

Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease.

P304

e16239

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0016239

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49800589

http://www.w3.org/2001/XMLSchema#string

P698

21283592

http://www.w3.org/2001/XMLSchema#string

P921

P932

3026813

http://www.w3.org/2001/XMLSchema#string